The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.
about
Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.PIASγ enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy19q13.11 microdeletion concomitant with ins(2;19)(p25.3;q13.1q13.4)dn in a boy: potential role of UBA2 in the associated phenotypeIdentification and Characterization of the Androgen Receptor From the American Alligator, Alligator mississippiensis.Regulation of germ cell function by SUMOylation.Sarcosine as a potential prostate cancer biomarker--a reviewMetabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.Targeting nuclear receptors with marine natural products.Overview on the complexity of androgen receptor-targeted therapy for prostate cancerNuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylationSUMO and the robustness of cancer.Loss of SUMOylation on ATF3 inhibits proliferation of prostate cancer cells by modulating CCND1/2 activity.Fighting polyglutamine disease by wrestling with SUMO.SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.
P2860
Q30405382-0CFD1D10-2B8B-4546-812D-651D5EC7C0A4Q34565891-83365885-04A0-449B-A917-94F2CFD29E7BQ34707139-96A7EC61-9115-4383-8940-77A395A5A91CQ35878814-1F66BBDD-BBEA-496B-BE67-2B2B948EE3ABQ36437164-493E2A63-A22E-4232-BDB6-5FE069DE21AFQ37091881-FA15DF5F-B899-4913-85BC-00F966E35124Q37570977-31371E41-DD6B-4825-8AAA-E77E06241E14Q37621100-A3650612-19D9-4F00-BC28-44804002D201Q38364166-0FBD9240-4EDF-4B3D-A8D7-3BB12B474842Q38965675-203A402C-C66F-4F70-9509-10284290AA34Q39108925-A71EC995-6B98-4FAF-8272-796A183458C1Q39165172-0B684280-9089-4A0C-AFEC-8E86EA7C3834Q43135526-1B5BFE74-3BB3-4448-BE66-ED52C576470BQ47554901-021D4C80-6DAF-4ECA-8D7F-185A60BEEB12
P2860
The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The in vivo role of androgen r ...... ues of synergy control motifs.
@ast
The in vivo role of androgen r ...... ues of synergy control motifs.
@en
type
label
The in vivo role of androgen r ...... ues of synergy control motifs.
@ast
The in vivo role of androgen r ...... ues of synergy control motifs.
@en
prefLabel
The in vivo role of androgen r ...... ues of synergy control motifs.
@ast
The in vivo role of androgen r ...... ues of synergy control motifs.
@en
P2093
P2860
P356
P1476
The in vivo role of androgen r ...... dues of synergy control motifs
@en
P2093
Eric Bolton
Osvaldo Cruz-Rodríguez
Sarmistha Mukherjee
P2860
P304
31195-31206
P356
10.1074/JBC.M112.395210
P407
P577
2012-07-24T00:00:00Z